PHP
CTLT

Parkman Healthcare Partners’s CATALENT, INC. CTLT Stock Holding History

Parkman Healthcare Partners’s Portfolio CTLT Stock Details CTLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-80,646
Closed -$3.67M – 109
2023
Q3 		$3.67M Sell
80,646
-60,604
-43% -$2.83M 0.67% 44
2023
Q2 		$6.12M Buy
+141,250
New +$6.2M 1.06% 30
2022
Q4 		– Sell
-45,304
Closed -$3.28M – 96
2022
Q3 		$3.28M Sell
45,304
-22,314
-33% -$2.22M 0.93% 39
2022
Q2 		$7.25M Sell
67,618
-11,431
-14% -$1.16M 2.67% 11
2022
Q1 		$8.77M Buy
79,049
+18,110
+30% +$1.89M 2.57% 13
2021
Q4 		$7.8M Buy
60,939
+21,200
+53% +$2.72M 1.72% 21
2021
Q3 		$5.29M Sell
39,739
-15,000
-27% -$1.87M 1.34% 24
2021
Q2 		$5.92M Sell
54,739
-24,787
-31% -$2.66M 1.29% 28
2021
Q1 		$8.38M Sell
79,526
-4,593
-5% -$512K 1.94% 16
2020
Q4 		$8.75M Sell
84,119
-5,897
-7% -$572K 2.24% 14
2020
Q3 		$7.71M Sell
90,016
-4,984
-5% -$421K 2.04% 16
2020
Q2 		$6.96M Buy
+95,000
New +$6.45M 1.96% 20

Other funds holding CTLT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Parkman Healthcare Partners's CTLT Position: Q4 2023 in Review

Parkman Healthcare Partners sold out of CATALENT, INC. (CTLT) in Q4 2023, closing a stake of 80,646 shares — an estimated $3.67M sold.

Parkman Healthcare Partners first reported a position in CTLT in Q2 2020 and held it in 12 quarters. The position peaked at $8.77M in Q1 2022. 424 funds tracked by Wall St. Rank hold CTLT as of Q4 2023.

  • Parkman Healthcare Partners reported no remaining CATALENT, INC. position as of Q4 2023 after selling out during the quarter.
  • Parkman Healthcare Partners sold 80,646 CATALENT, INC. shares in Q4 2023, an estimated $3.67M.
  • Parkman Healthcare Partners first reported a position in CATALENT, INC. in Q2 2020 and held it in 12 quarters.
  • Parkman Healthcare Partners's CATALENT, INC. position peaked at $8.77M in Q1 2022.
  • 424 funds tracked by Wall St. Rank held CATALENT, INC. as of Q4 2023.

Based on Parkman Healthcare Partners's 13F filing for Q4 2023, filed 14 Feb 2024.